Alberta expands access to Cystic Fibrosis medication to those aged two to five
EDMONTON, AB – The Government of Alberta has approved increased access to an important medication.
On December 13, 2023, the province announced that access to Trikafta has been expanded, allowing it to be given to children aged two to five.
Trikafta is used to treat Cystic Fibrosis, a genetic disease in which mucus accumulates in the lungs, digestive tract and other parts of the body, resulting in a persistent cough, shortness of breath, frequent chest infections and weight loss.
Alberta first allowed access to the prescription drug in 2021, allowing for users aged 12 and up to get it. The province then expanded access in 2022, following Health Canada approval for children aged six to 11.